Torso xl coil

All patients were scheduled for cardiac, hepatic and pancreatic MRI T2* at the Radiology Department, using a Philips Achiva, Netherland (1.5 Tesla) superconducting magnet with a Torso XL coil.
Scans were synchronized to the cardiac cycle using standard electrocardiogram gating. We then took a single 10 mm-thick short axis, mid ventricular slice positioned half way between the base and the apex of the left ventricle with repition time (TR) 20 ms and multiple echo times (TEs) (2.4, 4.6, 6.8, 9.1 and 11.3ms). Flip angle 30 and field of view (FOV) 320 mm. A fitting curve algorithm using a monoexponential decay with a constant offset (S=S0e-TE.R2*+C; S is the signal intensity, S0 is the signal intensity at TE=0 ms, and C is a constant) was applied to determine the T2* value. Results of cardiac T2* and myocardial iron concentration (MIC) measurements were considered as discontinuous variables and were classified as follows: normal iron concentration (T2* >20, MIC < 1.16 mg/g), light (T2* 15–20, MIC 1.16- 1.65 mg/g), moderate (T2* 10–15, MIC 1.65- 2.71 mg/g) and severe (T2* <10, MIC > 2.71 mg/g)
^{7 (link)}
.

All prostate mpMRIs were acquired with the patient in the supine position (feet first), using a 3T unit (Achieva, Philips Healthcare, Eindhoven, NL) with an external pelvic phased‐array coil (TorsoXL coil, Philips Healthcare, Eindhoven, NL) but without an endorectal coil. An antispasmodic agent (2 mls of 20 mg/mL hyoscine butylbromide; Buscopan®, Boeringer) was administered intravenously, to minimize peristalsis of the bowel and thereby reduce movement artifact on the image. The imaging protocol used was in accordance with the PI‐RADS v2 guidelines, with intravenous contrast injection of 0.1 ml/kg gabobenate dimeglumine (MultiHance®, Bracco Eisai, Tokyo, Japan), administered through a peripheral vein at a rate of 4 mL/s. The sequences acquired before contrast injection included axial, sagittal and coronal T2‐weighted fast spin‐echo (FSE), an axial T1‐weighted FSE, axial diffusion‐weighted images (DWI) using b0, b100 and b1500 to generate the apparent diffusion coefficient (ADC) map, and a separate high b value DWI (b2000s/mm²). During contrast injection, an axial three‐dimensional (3D) FSE dynamic contrast enhanced (DCE) sequence was acquired. After contrast injection, an axial T1‐weighted FSE sequence was acquired.